Tag: TMS
Magnus receives US FDA clearance for SAINT neuromodulation system in severe...
Magnus Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its SAINT neuromodulation system for the treatment of...
Sham-controlled studies indicate effectiveness of TMS for negative schizophrenia symptoms
A systematic review and meta-analysis published in Nature Schizophrenia has concluded that data from sham-controlled studies to date indicate the effectiveness of transcranial magnetic...
Neuromodulation for post-stroke recovery advancing on several fronts
As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...
MagVenture introduces MagVenture Flow Arm use in non-invasive brain stimulation
MagVenture has introduced the MagVenture Flow Arm — a patent-pending, clinical positioning system to optimise the delivery of MagVenture's FDA cleared protocols for non-invasive...
New published data affirms BrainsWay’s deep TMS system for the treatment...
BrainsWay has announced new data from an article published in the lastest issue of the American Journal of Psychiatry demonstrating that its deep TMS (dTMS) system...
Neuronix submits neuroAD System for FDA clearance
Neuronix has announced positive results from its pivotal, double-blind placebo-controlled, multicentre clinical study, for the assessment of safety and efficacy of the neuroAD Therapy...
